Home » Stocks » Liquidia Technologies

Liquidia Technologies, Inc. (LQDA)

Stock Price: $7.79 USD -0.49 (-5.92%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 221.02M
Revenue (ttm) 8.07M
Net Income (ttm) -48.61M
Shares Out 28.37M
EPS (ttm) -2.25
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $7.79
Previous Close $8.28
Change ($) -0.49
Change (%) -5.92%
Day's Open 8.49
Day's Range 7.71 - 8.75
Day's Volume 1,061,741
52-Week Range 2.65 - 12.10

More Stats

Market Cap 221.02M
Enterprise Value 203.47M
Earnings Date (est) Aug 6, 2020
Ex-Dividend Date n/a
Shares Outstanding 28.37M
Float 15.80M
EPS (basic) -2.27
EPS (diluted) -2.25
FCF / Share -1.91
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.42M
Short Ratio 5.33
Short % of Float 8.24%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 27.38
PB Ratio 14.33
Revenue 8.07M
Operating Income -47.78M
Net Income -48.61M
Free Cash Flow -54.40M
Net Cash 17.54M
Net Cash / Share 0.62
Gross Margin 90.00%
Operating Margin -591.96%
Profit Margin -602.20%
FCF Margin -673.92%
ROA -47.22%
ROE -164.53%
ROIC -215.00%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$35.33*
(353.53% upside)
Low
25.0
Current: 7.79
High
41.0
Target: 35.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016
Revenue8.072.717.2613.22
Revenue Growth198.2%-62.7%-45.08%-
Gross Profit7.262.596.9412.30
Operating Income-46.82-34.87-28.03-15.86
Net Income-47.58-53.14-29.15-15.93
Shares Outstanding18.487.160.560.44
Earnings Per Share-2.59-7.51-51.78-36.42
Operating Cash Flow-48.28-31.83-24.29-13.95
Capital Expenditures-1.85-0.87-2.54-2.89
Free Cash Flow-50.13-32.70-26.83-16.83
Cash & Equivalents55.8039.533.421.44
Total Debt24.4212.7722.158.68
Net Cash / Debt31.3826.76-18.73-7.24
Assets68.8449.4214.848.49
Liabilities33.8930.7348.5426.73
Book Value34.9518.69-33.69-18.25
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Liquidia Technologies, Inc.
Country United States
Employees 64
CEO Neal F. Fowler

Stock Information

Ticker Symbol LQDA
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: LQDA
IPO Date July 26, 2018

Description

Liquidia Technologies, Inc., a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of novel products utilizing its proprietary PRINT technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to enhance the safety, efficacy, and performance of a range of therapies. Its lead product candidate, LIQ861, an inhaled dry powder formulation of treprostinil that has completed Phase III clinical trial for the treatment of pulmonary arterial hypertension. The company is also developing LIQ865 for the treatment of local post-operative pain that is in Phase II-enabling toxicology studies. It has collaboration agreements with GlaxoSmithKline plc and the University of North Carolina. Liquidia Technologies, Inc. was founded in 2004 and is headquartered in Morrisville, North Carolina.